Facebook
Twitter
LinkedIn
ForwardMCI Oncology Academic Educational Series: Emergent Complications of Cancer Therapy: Hypersensitivity/Infusion Reactions and the Impact of Febrile Neutropenia
The use of anthracycline-based combination chemotherapy to treat diffuse aggressive non-Hodgkin lymphoma (NHL) in older patients is complicated by the frequent occurrence of neutropenia, febrile neutropenia (FN), and serious infections.
During this lecture Ms. Sinclair and Ms. Alonso will discuss early recognition of hypersensitivity reaction along with immediate and post-care for infusion reaction.
Target Audience
Oncology Nurses, Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, Pharmacists, Patient Navigators and other interested healthcare providers.
Learning Objectives
- Discuss early recognition, immediate and post-care for infusion reactions, cytokine release syndrome, and anaphylaxis.
- Define severe and febrile neutropenia in cancer patients, discuss relationship between ANC and risk of infection and discuss short and long-term mortality associated with febrile neutropenia.
Miri M. Sinclair, ARNP
Miami Cancer Institute
Miri M. Sinclair, ARNP indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in her presentation(s) or discussion(s).
Dayne Alonso, P.A.
Dayne Alonso, P.A. indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in her presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1.5 credit hours, CE Broker Course #20-665784, by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants.
This activity has also been approved for 1.5 credits for Nurse Practitioners, Nurses and Pharmacists. Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.50 AMA PRA Category 1 Credit™
- 1.50 General certificate of attendance
- 1.50 Nurse Practitioners
- 1.50 Florida Board of Nursing
- 1.50 Florida Board of Occupational Therapy
- 1.50 Florida Board of Pharmacy
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.